ATE552867T1 - Alginatbeschichtete collagenmatrix- zellvorrichtung, herstellungsverfahren dafür und verwendungen davon - Google Patents

Alginatbeschichtete collagenmatrix- zellvorrichtung, herstellungsverfahren dafür und verwendungen davon

Info

Publication number: ATE552867T1
Authority: AT; Austria
Prior art keywords: collagen matrix; production method; cell device; matrix cell; coated collagen
Prior art date: 2006-06-16

Application number

AT07765405T

Other languages

English (en)

Inventor

Denis Dufrane

Pierre Rene Raymond Gianello

Jan Egil Melvik

Original Assignee

Fmc Biopolymer As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-16

Filing date

2007-06-13

Publication date

2012-04-15

2007-06-13 Application filed by Fmc Biopolymer As filed Critical Fmc Biopolymer As

2012-04-15 Application granted granted Critical

2012-04-15 Publication of ATE552867T1 publication Critical patent/ATE552867T1/de

Links

FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 title abstract 2
102000008186 Collagen Human genes 0.000 title abstract 2
108010035532 Collagen Proteins 0.000 title abstract 2
229940072056 alginate Drugs 0.000 title abstract 2
235000010443 alginic acid Nutrition 0.000 title abstract 2
229920000615 alginic acid Polymers 0.000 title abstract 2
229920001436 collagen Polymers 0.000 title abstract 2
239000011159 matrix material Substances 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title 1
238000000034 method Methods 0.000 abstract 3
230000001413 cellular effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0068—General culture methods using substrates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
- A61L27/3891—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types as distinct cell layers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
- C12N2533/74—Alginate

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Botany (AREA)
Dermatology (AREA)
Cell Biology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Transplantation (AREA)
Oral & Maxillofacial Surgery (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Urology & Nephrology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Vascular Medicine (AREA)
Diabetes (AREA)
Endocrinology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Materials For Medical Uses (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

AT07765405T 2006-06-16 2007-06-13 Alginatbeschichtete collagenmatrix- zellvorrichtung, herstellungsverfahren dafür und verwendungen davon ATE552867T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US81440406P	2006-06-16	2006-06-16
PCT/EP2007/055857 WO2007144389A2 (en)	2006-06-16	2007-06-13	Alginate coated, collagen matrix cellular device, preparative methods, and uses thereof

Publications (1)

Publication Number	Publication Date
ATE552867T1 true ATE552867T1 (de)	2012-04-15

Family

ID=38666842

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07765405T ATE552867T1 (de)	2006-06-16	2007-06-13	Alginatbeschichtete collagenmatrix- zellvorrichtung, herstellungsverfahren dafür und verwendungen davon

Country Status (5)

Country	Link
US (1)	US8168215B2 (de)
EP (1)	EP2029727B1 (de)
AT (1)	ATE552867T1 (de)
ES (1)	ES2386123T3 (de)
WO (1)	WO2007144389A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9056151B2 (en) *	2007-02-12	2015-06-16	Warsaw Orthopedic, Inc.	Methods for collagen processing and products using processed collagen
US20080260794A1 (en) *	2007-02-12	2008-10-23	Lauritzen Nels J	Collagen products and methods for producing collagen products
EP2152860A4 (de) *	2007-06-13	2011-12-07	Fmc Corp	Peptidgebundene zellmatrixmaterialien für stammzellen und ihre verwendung
EP2155810A4 (de) *	2007-06-13	2013-07-03	Fmc Corp	Alginatbeschichteter, polysaccharidgelhaltiger schaumverbundstoff, herstellungsverfahren und verwendungen davon
RU2391399C2 (ru) *	2008-07-31	2010-06-10	Государственное Образовательное Учреждение Высшего Профессионального Образования "Красноярский Государственный Медицинский Университет Имени Профессора В.Ф. Войно-Ясенецкого Министерства Здравоохранения И Социального Развития Российской Федерации" (Гоу Впо Красгму Им.Проф.В.Ф.Войно-Ясенецкого)	Способ получения клеточной матрицы кожи
US9540630B2 (en)	2008-09-17	2017-01-10	Beta O2 Technologies Ltd.	Optimization of alginate encapsulation of islets for transplantation
DE102010001179A1 (de) *	2010-01-25	2011-07-28	Technische Universität Dresden, 01069	Verwendung von Hydrogelen auf Basis guluronsäure- und/oder mannuronsäurehaltiger Polysaccharide zur Behandlung von Beschädigungen des Nervensystems, zur Förderung des Nervenwachstums, zur Behandlung von neurodegenerativen Erkrankungen und zur Kultivierung von Neuronen
US8460691B2 (en)	2010-04-23	2013-06-11	Warsaw Orthopedic, Inc.	Fenestrated wound repair scaffold
US8790699B2 (en)	2010-04-23	2014-07-29	Warsaw Orthpedic, Inc.	Foam-formed collagen strand
WO2011154941A2 (en)	2010-06-07	2011-12-15	Beta-O2 Technologies Ltd.	Multiple-layer immune barrier for donor cells
CN107648668B (zh) *	2010-10-06	2021-06-18	哈佛学院董事会	用于基于材料的细胞疗法的可注射的成孔水凝胶
US20130336940A1 (en)	2011-02-23	2013-12-19	Universite Catholique De Louvain	Modified pig islets for diabetes treatment
KR101327630B1 (ko) *	2012-03-05	2013-11-13	울산대학교 산학협력단	아텔로콜라겐을 이용한 췌도세포 이식용 담체의 제조방법 그리고 이를 이용하여 제조된 인공췌장
GB201301618D0 (en)	2013-01-30	2013-03-13	Ge Healthcare Uk Ltd	Solid medium for the storage of Biological Material
AU2014248873B2 (en)	2013-03-13	2017-03-23	Allosource	Fascia fibrous compositions and methods for their use and manufacture
US10202636B2 (en) *	2013-12-24	2019-02-12	General Electric Company	Electrospun fibers for protein stabilization and storage
PL3129467T3 (pl)	2014-04-11	2020-05-18	Université Catholique de Louvain	Wysepki od świni transgenicznej i ich zastosowania w leczeniu cukrzycy
EP3149026B1 (de) *	2014-06-02	2025-03-05	B.G. Negev Technologies and Applications Ltd.	Stellenselektive modifikation von polysacchariden und anwendungen davon
WO2016061450A1 (en) *	2014-10-16	2016-04-21	Beth Israel Deaconess Medical Center, Inc.	Collagen-alginate constructs and uses thereof
US11471419B2 (en)	2016-09-30	2022-10-18	The Board Of Trustees Of The University Of Illinois	Capsules with intracapsular microspheres for improved survival and function of encapsulated cells
US10772986B2 (en)	2017-01-26	2020-09-15	Allosource	Fascia fibrous compositions and methods for their use and manufacture
KR20230079403A (ko) *	2020-10-09	2023-06-07	더 리젠츠 오브 더 유니버시티 오브 캘리포니아	이식편 거부반응을 치료하기 위한 면역공학 생체물질

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2128551A (en)	1934-01-11	1938-08-30	Algin Corp Of America	Method of treating seaweed
US2036934A (en)	1934-04-21	1936-04-07	Kelco Co	Process for making alginic acid and product
US2426125A (en)	1944-04-03	1947-08-19	Kelco Co	Manufacture of glycol alginates
US3772266A (en)	1972-10-19	1973-11-13	Kelco Co	Process for the preparation of propylene glycol alginate from partially neutralized alginic acid
CA1019326A (en)	1974-07-16	1977-10-18	Uniroyal Ltd.	Process for the production of alkylene glycol alginates
US5429821A (en)	1992-05-29	1995-07-04	The Regents Of The University Of California	Non-fibrogenic high mannuronate alginate coated transplants, processes for their manufacture, and methods for their use
US5578314A (en) *	1992-05-29	1996-11-26	The Regents Of The University Of California	Multiple layer alginate coatings of biological tissue for transplantation
DK1666585T3 (da)	1994-01-13	2009-01-12	Rogosin Inst	Makroindkapslede sekretoriske celler
US5916790A (en)	1995-03-03	1999-06-29	Metabolex, Inc.	Encapsulation compositions, and methods
CA2214088A1 (en) *	1995-03-03	1996-09-12	Metabolex Inc.	Novel encapsulation process by a gelling polymer
US6126936A (en)	1995-03-10	2000-10-03	Biohybrid Technologies Llc	Microcapsules and composite microreactors for immunoisolation of cells
US5855613A (en)	1995-10-13	1999-01-05	Islet Sheet Medical, Inc.	Retrievable bioartificial implants having dimensions allowing rapid diffusion of oxygen and rapid biological response to physiological change
US6419920B1 (en) *	1995-10-25	2002-07-16	Trans Karyotic Therapies, Inc.	Hybrid matrix implants and explants
IL118376A0 (en)	1996-05-22	1996-09-12	Univ Ben Gurion	Polysaccharide sponges for cell culture and transplantation
ES2317657T3 (es)	1996-09-19	2009-04-16	The Regents Of The University Of Michigan	Polimeros que contienen polisacaridos tales como alginatos o alginatos modificados.
US6171610B1 (en)	1998-04-24	2001-01-09	University Of Massachusetts	Guided development and support of hydrogel-cell compositions
DE60040648D1 (de)	1999-01-21	2008-12-11	Adv Med Solutions Ltd	Träger zum zellwachstum
US6699470B1 (en)	1999-10-12	2004-03-02	Massachusetts Institute Of Technology	Mesh-gel constructs for cell delivery containing enzymes and/or enzyme inhibitors to control gel degradation
AU2002213143A1 (en)	2000-10-12	2002-04-22	Institute Of Materials Research And Engineering	Non-disruptive three-dimensional culture and harvest system for anchorage-dependent cells
CA2548305C (en) *	2003-12-23	2014-07-15	Fmc Biopolymer As	Use of alginate matrices to control cell growth
EP1799232B1 (de) *	2004-10-12	2015-10-07	FMC Biopolymer AS	Selbstgelierende alginatsysteme und verwendungsmöglichkeiten dafür

2007
- 2007-06-13 ES ES07765405T patent/ES2386123T3/es active Active
- 2007-06-13 EP EP07765405A patent/EP2029727B1/de not_active Not-in-force
- 2007-06-13 AT AT07765405T patent/ATE552867T1/de active
- 2007-06-13 US US11/762,680 patent/US8168215B2/en not_active Expired - Fee Related
- 2007-06-13 WO PCT/EP2007/055857 patent/WO2007144389A2/en not_active Ceased

Also Published As

Publication number	Publication date
WO2007144389A3 (en)	2008-02-14
EP2029727B1 (de)	2012-04-11
EP2029727A2 (de)	2009-03-04
US20080050417A1 (en)	2008-02-28
WO2007144389A2 (en)	2007-12-21
ES2386123T3 (es)	2012-08-09
US8168215B2 (en)	2012-05-01

Publication	Publication Date	Title
ATE552867T1 (de)	2012-04-15	Alginatbeschichtete collagenmatrix- zellvorrichtung, herstellungsverfahren dafür und verwendungen davon
FR23C1028I1 (fr)	2023-10-06	Mutant de polypeptide du facteur ix, ses utilisations et son procédé de production
MX368000B (es)	2019-09-13	Composición de colágeno y ácido hialurónico para la reparación de ligamento o tendón.
EA201000114A1 (ru)	2010-06-30	Проппант и способ гидравлического разрыва пласта (варианты)
BR112013027307A2 (pt)	2017-12-12	método para tratar uma matriz de tecido; matriz de tecido acelular
EP4131408C0 (de)	2026-01-28	Anzeigesubstrat und herstellungsverfahren dafür sowie anzeigevorrichtung
CY1123085T1 (el)	2021-10-29	Yδρογελες θειïκου αλγινικου αλατος για κυτταρικη καλλιεργεια και θεραπεια
MX344581B (es)	2016-12-19	Reticulantes borónicos multifuncionales y métodos asociados.
EP1896177A4 (de)	2011-10-05	Kobaltoxidkatalysator zur wasserstofferzeugung und herstellungsverfahren dafür
ATE539721T1 (de)	2012-01-15	Vorrichtung zur wundbehandlung
WO2010006055A3 (en)	2010-03-04	Improved gas permeable cell culture device and method of use
EP2002484A4 (de)	2016-06-08	Verfahren und struktur für die herstellung von solarzellen mittels schichtübertragungsverfahren
GB0802912D0 (en)	2008-03-26	Thin-film transistor, carbon-based layer and method of production thereof
EP2463353A4 (de)	2014-05-28	Fluoreszierende substanz, verfahren zu ihrer herstellung und lumineszierende vorrichtung damit
EP2452537A4 (de)	2016-01-20	Mobilstation, basisstation und betriebsverfahren für die mobilstation
MY162957A (en)	2017-07-31	Polymer foam cell morphology control and use in borehole filtration devices
CL2015003188A1 (es)	2016-07-01	Divisional de la solicitud 578-2014 por composición controladora de enfermedades en plantas y métodos para controlar enfermedades en plantas
ATE536192T1 (de)	2011-12-15	Vernetzte hyaluronsäure und kollagen und ihre verwendungen
DE602008000105D1 (de)	2009-10-08	Lagermatte, dessen Herstellungsverfahren, Abgasbehandlungsvorrichtung und dessen Herstellungsverfahren und Dämpfungsvorrichtung
EP2295563A4 (de)	2012-05-30	B-amylase, dafür codierendes gen und herstellungsverfahren dafür
EP2573125A4 (de)	2014-07-23	Konjugiertes polymer mit dithienpyrrol-chinoxalin, herstellungsverfahren und verwendung
WO2010077266A9 (en)	2010-09-30	Method of dynamic binary temperature therapy
WO2009111310A3 (en)	2009-10-29	Treating cleft palate
CO6270379A2 (es)	2011-04-20	Aparato de adelgazamiento escurrimiento desprendimiento para caracterizar barras antitranspirantes y desodorantes
EP2018394A4 (de)	2010-06-16	Herstellung von biowasserstoff durch einen künstlichen enzymweg